ELIQUIS inhibits free and clot-bound factor Xa, and prothrombinase activity.
ELIQUIS has no direct effects on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting factor Xa, ELIQUIS prevents thrombin generation and thrombus development.
Keywords: Animation, 3D, Models, Product Demonstration, Professional Education, Interactive, Molecular Biology, Mechanism of Action (MOA), Health & Wellness
© Jamie Denham